BioDelivery Sciences International Inc. (BDSI) News

News for BioDelivery Sciences International Inc. (BDSI)

Sector News | Topic News

Fri, Jan 06, 2012

6:00 AM

BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine - PR Newswire

6:00 AM

Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine - PR Newswire

Thu, Dec 29, 2011

2:37 PM

ONSOLIS to Benefit from Approval of Class-Wide REMS for All Transmucosal Fentanyl Products - PR Newswire

Tue, Dec 20, 2011

4:22 PM

BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study - PR Newswire

Mon, Nov 28, 2011

7:00 AM

US Patent Office Rejects All 191 Claims in Key MonoSol Patent Asserted Against BioDelivery Sciences - PR Newswire

Mon, Nov 21, 2011

7:00 AM

BioDelivery Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference - PR Newswire

Mon, Nov 14, 2011

7:00 AM

BioDelivery Sciences to Host Business Update Webcast and Conference Call on Tuesday, November 15, 2011 at 8:30 AM Eastern Time - PR Newswire

Thu, Nov 10, 2011

7:00 AM

BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone - PR Newswire

Mon, Nov 07, 2011

8:58 AM

BEMA Fentanyl Submitted for Marketing Authorization in Taiwan - PR Newswire

Tue, Oct 25, 2011

7:00 AM

Samuel J. Sears, Jr. Appointed to BioDelivery Sciences Board of Directors - PR Newswire

Fri, Sep 30, 2011

9:00 AM

Global Situation & Resulting Influences - Research Report on BioDelivery Sciences International, Inc. and Watson Pharmaceuticals, Inc. - Marketwire

Wed, Sep 28, 2011

5:16 PM

BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain - PR Newswire

Tue, Sep 06, 2011

7:00 AM

BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence - PR Newswire

Wed, Aug 31, 2011

7:00 AM

BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences - PR Newswire

Mon, Aug 22, 2011

7:00 AM

BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada - PR Newswire

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.